Welcome to our dedicated page for Lumentum Hldgs SEC filings (Ticker: LITE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. SEC filings for Lumentum Holdings Inc. (NASDAQ: LITE), a San Jose, California-based designer and manufacturer of optical and photonic products. Through these documents, investors can review how Lumentum reports its financial results, capital structure, and governance practices, and how it describes its role in optical networking, data center infrastructure, and laser applications.
Lumentum’s annual reports on Form 10-K and quarterly reports on Form 10-Q detail its operations in optical communications and laser technologies, including segment information, risk factors, and management’s discussion and analysis. Earnings-related Form 8-K filings furnish press releases that present both GAAP and non-GAAP metrics, with reconciliations and explanations of adjustments such as stock-based compensation, acquisition-related costs, amortization of acquired intangibles, restructuring charges, and tax items.
The company also uses Form 8-K to disclose capital markets transactions, such as its 0.375% Convertible Senior Notes due 2032, associated indentures, and capped call transactions, as well as the repurchase of existing convertible notes. These filings explain terms like conversion rates, redemption conditions, and events of default, giving insight into Lumentum’s financing strategy and debt profile.
Governance and compensation matters appear in proxy statements on Form DEF 14A, which describe board composition, committee responsibilities, executive compensation programs, equity incentive plans such as the 2025 Equity Incentive Plan, and the agenda and voting results for annual stockholder meetings. Additional filings, including registration statements and Forms S-8 referenced in 8-K exhibits, cover share-based compensation arrangements.
On Stock Titan, these filings are updated in near real time from EDGAR and paired with AI-powered summaries that highlight key points from lengthy documents. Users can quickly see what changed in a new 10-K or 10-Q, how a financing transaction affects Lumentum’s capital structure, or what a governance-related filing means, without reading every page. For deeper analysis, investors can still open the full text of each filing, including exhibits related to debt instruments, equity plans, and other material agreements.
Lumentum (NASDAQ:LITE) filed a Form 4 revealing director Alan S. Lowe sold 20,000 common shares on 06/26/2025 at $93.47, generating roughly $1.87 million. The trade, executed under a Rule 10b5-1 plan adopted 11/20/2024, reduced his direct stake by about 8% to 230,471 shares.
No derivative transactions were reported. While pre-scheduled, the sale size exceeds materiality thresholds and may influence investor sentiment.
Lumentum Holdings Director Alan S. Lowe has filed a Form 144 indicating intent to sell 20,000 shares of common stock with an aggregate market value of $1,869,400. The planned sale is scheduled for June 26, 2025, through Morgan Stanley Smith Barney on NASDAQ.
The shares to be sold were acquired through multiple transactions between August 2022 and February 2023, including:
- Restricted Stock grants totaling 5,824 shares
- Performance Share awards totaling 14,176 shares
Notable recent trading activity shows Lowe has sold 30,000 shares in the past three months for total gross proceeds of approximately $2.6 million. The filing indicates Lowe is trading under a 10b5-1 plan adopted on November 20, 2024, and affirms no knowledge of undisclosed material adverse information regarding Lumentum's operations.
Director Alan S. Lowe of Lumentum Holdings has reported a significant insider transaction, selling 20,000 shares of Common Stock at $88.47 per share on June 18, 2025. The transaction was executed under a Rule 10b5-1 trading plan established on November 20, 2024.
Following the sale, Lowe maintains direct ownership of 250,471 shares of Lumentum Holdings. The transaction was reported via Form 4 filing, with attorney Jae Kim signing as the authorized representative on June 20, 2025.
- Transaction value: Approximately $1.77 million
- Trading plan: Executed under pre-established Rule 10b5-1 plan
- Position: Director (Non-executive board member)
- Ownership: Direct beneficial ownership
Lumentum Holdings Form 144 filing details a proposed sale of securities by an insider. The filing indicates plans to sell 20,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,769,400.
The securities to be sold were acquired through two transactions:
- 8,280 shares as Restricted Stock on August 31, 2022
- 11,720 shares as Performance Shares on August 22, 2022
Recent trading activity by the seller (Alan S. Lowe) in the past 3 months includes three sales on June 4, 2025, totaling 10,000 shares with combined gross proceeds of $835,800. The sale will be executed on the NASDAQ, with an approximate sale date of June 18, 2025. The company currently has approximately 69.4 million shares outstanding.
FAQ
What is the current stock price of Lumentum Hldgs (LITE)?
What is the market cap of Lumentum Hldgs (LITE)?
